Many antibiotics work by inhibiting bacterial translation. Why would a drug shown to inhibit viral translation never be licensed for use in humans?

You plan to synthesize a peptide to be used as a vaccine to treat melanoma, a particularly aggressive form of skin cancer. Normally, gp100, a protein on the surface of melanocytes, activates cell growth when it is bound by its ligand. Activation of the growth pathway depends on the presence of threonine in the ligand. The effective peptide vaccine will mimic the natural ligand, but won’t cause cell growth and division. Below is the sequence of the natural ligand:   LDMKTAG   In order to ensure your newly designed peptide vaccine does not cause cell growth upon binding, you must substitute the Threonine residue at position 5. What amino acid would you replace it with, bearing in mind that the peptide should still be similar enough to bind to the gp100 protein in the surface of melanocytes. Explain your choice. Your vaccine will be administered as a topical cream, and you require your peptide to have an overall neutral charge in order to be functional. At what pH should you formulate…

When choosing a "first line" drug to treat an infection, the most important characteristic would be? the specific mechanism of action bactericidal broad spectrum low toxicity (fewest side effects) In what cell type can both transcription and translation occur simultaneously? both prokaryotic and eukaryotic cells neither prokaryotic and eukaryotic cells prokaryotic cells eukaryotic cells

How is the ribosome a target in terms of antibiotic action mechanisms?   https://www.youtube.com/watch?v=IVBCrzjOl40